MedTrace Logo

Gut Microbiota and Color-rectal Cancer.

NCT04662853 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 153

Last updated 2020-12-10

No results posted yet for this study

Summary

This clinical trial is focused in the development of a screening test for the people at risk of colo-rectal cancer (aged more than 50 years old), valid and safe, improving the screening prognosis increasing the sensitivity and sensitive as compared with the current method, fecal occult blood.

Conditions

  • Cancer
  • Colo-rectal Cancer
  • Diagnoses Disease
  • Microbiota-related Disease
  • Intestinal Disease

Interventions

DIAGNOSTIC_TEST

Gut microbiota determination from feces samples.

Determination of the gut microbiota composition by 16S metagenomic and building of a mathematical model, on the basis of the colonoscopies results, able to classify patients without and with color-rectal cancer-related lessions. These latter will be also classified according to the type of lession.

Sponsors & Collaborators

  • Reina Sofia University Hospital

    collaborator UNKNOWN

  • Junta de Andalucia

    collaborator OTHER_GOV

  • Maimónides Biomedical Research Institute of Córdoba

    lead OTHER

Principal Investigators

  • Antonio Hervas · Reina Sofia University Hospital

  • Carmen Haro, PhD · Maimonides Institute for Biomedical Research

  • Antonio Camargo, PhD · Maimonides Institute for Biomedical Research

Eligibility

Min Age
50 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-17
Primary Completion
2021-07-31
Completion
2021-07-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04662853 on ClinicalTrials.gov